209 related articles for article (PubMed ID: 36308820)
41. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
[TBL] [Abstract][Full Text] [Related]
42. Blunted salivary cortisol response to psychosocial stress in women with posttraumatic stress disorder.
Metz S; Duesenberg M; Hellmann-Regen J; Wolf OT; Roepke S; Otte C; Wingenfeld K
J Psychiatr Res; 2020 Nov; 130():112-119. PubMed ID: 32805520
[TBL] [Abstract][Full Text] [Related]
43. Cortisol awakening response in adolescents with acute sexual abuse related posttraumatic stress disorder.
Keeshin BR; Strawn JR; Out D; Granger DA; Putnam FW
Depress Anxiety; 2014 Feb; 31(2):107-14. PubMed ID: 23893710
[TBL] [Abstract][Full Text] [Related]
44. C-reactive protein, pre- and postdexamethasone cortisol levels in post-traumatic stress disorder.
Spitzer C; Wibisono D; Terfehr K; Löwe B; Otte C; Wingenfeld K
Nord J Psychiatry; 2014 Jul; 68(5):296-9. PubMed ID: 24134123
[TBL] [Abstract][Full Text] [Related]
45. Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder.
Lee RS; Oswald LM; Wand GS
Alcohol Res; 2018; 39(2):147-159. PubMed ID: 31198654
[TBL] [Abstract][Full Text] [Related]
46. Dynamics and determinants of cortisol and alpha-amylase responses to repeated stressors in recent interpersonal trauma survivors.
Morris MC; Bailey B; Hellman N; Williams A; Lannon EW; Kutcher ME; Schumacher JA; Rao U
Psychoneuroendocrinology; 2020 Dec; 122():104899. PubMed ID: 33070022
[TBL] [Abstract][Full Text] [Related]
47. The Relationship between Cortisol Activity during Cognitive Task and Posttraumatic Stress Symptom Clusters.
Duan H; Wang L; Zhang L; Liu J; Zhang K; Wu J
PLoS One; 2015; 10(12):e0144315. PubMed ID: 26630485
[TBL] [Abstract][Full Text] [Related]
48. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses.
Shalev AY; Videlock EJ; Peleg T; Segman R; Pitman RK; Yehuda R
Int J Neuropsychopharmacol; 2008 May; 11(3):365-72. PubMed ID: 17971262
[TBL] [Abstract][Full Text] [Related]
49. Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study.
Michopoulos V; Norrholm SD; Stevens JS; Glover EM; Rothbaum BO; Gillespie CF; Schwartz AC; Ressler KJ; Jovanovic T
Psychoneuroendocrinology; 2017 Sep; 83():65-71. PubMed ID: 28595089
[TBL] [Abstract][Full Text] [Related]
50. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial.
Rauch SA; King AP; Abelson J; Tuerk PW; Smith E; Rothbaum BO; Clifton E; Defever A; Liberzon I
Depress Anxiety; 2015 Mar; 32(3):204-12. PubMed ID: 25639570
[TBL] [Abstract][Full Text] [Related]
51. Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD.
Usta MB; Gumus YY; Say GN; Bozkurt A; Şahin B; Karabekiroğlu K
Nord J Psychiatry; 2018 Apr; 72(3):164-172. PubMed ID: 29171317
[TBL] [Abstract][Full Text] [Related]
52. Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis.
Vries GJ; Mocking R; Assies J; Schene A; Olff M
Psychoneuroendocrinology; 2017 Dec; 86():209-217. PubMed ID: 28987899
[TBL] [Abstract][Full Text] [Related]
53. Role of enhanced glucocorticoid receptor sensitivity in inflammation in PTSD: insights from computational model for circadian-neuroendocrine-immune interactions.
Somvanshi PR; Mellon SH; Yehuda R; Flory JD; Makotkine I; Bierer L; Marmar C; Jett M; Doyle FJ
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E48-E66. PubMed ID: 32315214
[TBL] [Abstract][Full Text] [Related]
54. Diurnal salivary cortisol in pediatric posttraumatic stress disorder.
Carrion VG; Weems CF; Ray RD; Glaser B; Hessl D; Reiss AL
Biol Psychiatry; 2002 Apr; 51(7):575-82. PubMed ID: 11950459
[TBL] [Abstract][Full Text] [Related]
55. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions.
Dunlop BW; Wong A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071
[TBL] [Abstract][Full Text] [Related]
56. Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder.
Bonne O; Brandes D; Segman R; Pitman RK; Yehuda R; Shalev AY
Psychiatry Res; 2003 Jul; 119(1-2):171-5. PubMed ID: 12860372
[TBL] [Abstract][Full Text] [Related]
57. Gender moderates diurnal cortisol in relation to trauma and PTSD symptoms: A study in Sri Lankan adolescents.
Nicolson NA; Ponnamperuma T
Psychoneuroendocrinology; 2019 Jun; 104():122-131. PubMed ID: 30844606
[TBL] [Abstract][Full Text] [Related]
58. Pre-treatment cortisol awakening response predicts symptom reduction in posttraumatic stress disorder after treatment.
Rapcencu AE; Gorter R; Kennis M; van Rooij SJH; Geuze E
Psychoneuroendocrinology; 2017 Aug; 82():1-8. PubMed ID: 28482208
[TBL] [Abstract][Full Text] [Related]
59. Elevated cortisol in healthy female adolescent offspring of mothers with posttraumatic stress disorder.
Liu K; Ruggero CJ; Goldstein B; Klein DN; Perlman G; Broderick J; Kotov R
J Anxiety Disord; 2016 May; 40():37-43. PubMed ID: 27088877
[TBL] [Abstract][Full Text] [Related]
60. [Biological factors of post-traumatic stress: neuroendocrine aspects].
Birmes P; Escande M; Gourdy P; Schmitt L
Encephale; 2000; 26(6):55-61. PubMed ID: 11217539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
